FDA official logo
GSRS logoPFDA official logo

NAVEPEGRITIDE

UNII:Y3BH8M899D
Formula:
Preferred Substance Name:NAVEPEGRITIDE
GSRS Full Record:
Y3BH8M899D
i

  • 2413551-27-4
  • ACP-015
  • C-TYPE NATRIURETIC PEPTIDE (CNP), HUMAN, (89-126)-FRAGMENT (1-38) (CNP-38), CONJUGATED AT N6 OF LYS26 WITH FOUR O-METHYLPOLY(ETHYLENE GLYCOL) CHAINS (APPROX. 10 KDA EACH) VIA A CLEAVABLE TETRA-ANTENNARY LINKER; L-LEUCYL-L-GLUTAMINYL-L-.ALPHA.-GLUTAMYL-L-HISTIDYL-L-PROLYL-L-ASPARAGINYL-L-ALANYL-L-ARGINYL-L-LYSYL-L-TYROSYL-L-LYSYLGLYCYL-L-ALANYL-L-ASPARAGINYL-L-LYSYL-L-LYSYLGLYCYL-L-LEUCYL-L-SERYL-L-LYSYLGLYCYL-L-CYSTEINYL-L-PHENYLALANYLGLYCYL-L-LEUCYL-N6-(N2-(N2,N6-BIS(6-(((3RS)-1-(3-((3-((2RS)-2,3-BIS(.ALPHA.-METHYLPOLY(OXYETHYLENE)-.OMEGA.-OXY)PROPOXY)PROPYL)AMINO)-3-OXOPROPYL)-2,5-DIOXOPYRROLIDIN-3-YL)SULFANYL)HEXANOYL)-L-LYSYL)-N2-METHYL-N1-(2-(METHYLAMINO)ETHYL)-L-ISOASPARAGINYL)-L-LYSYL-L-LEUCYL-L-.ALPHA.-ASPARTYL-L-ARGINYL-L-ISOLEUCYLGLYCYL-L-SERYL-L-METHIONYL-L-SERYLGLYCYL-L-LEUCYLGLYCYL-L-CYSTEINE (22-38)-DISULFIDE
  • NAVEPEGRITIDE [INN]
  • NAVEPEGRITIDE [USAN]
  • POLY(OXY-1,2-ETHANEDIYL), .ALPHA.-HYDRO-.OMEGA.-METHOXY-, 26,26,26,26-TETRAETHER WITH L-LEUCYL-L-GLUTAMINYL-L-.ALPHA.-GLUTAMYL-L-HISTIDYL-L-PROLYL-L-ASPARAGINYL-L-ALANYL-L-ARGINYL-L-LYSYL-L-TYROSYL-L-LYSYLGLYCYL-L-ALANYL-L-ASPARAGINYL-L-LYSYL-L-LYSYLGLYCYL-L-LEUCYL-L-SERYL-L-LYSYLGLYCYL-L-CYSTEINYL-L-PHENYLALANYLGLYCYL-L-LEUCYL-N6-(N2,N6-BIS(6-((1-(3-((3-(2,3-DIHYDROXYPROPOXY)PROPYL)AMINO)-3-OXOPROPYL)-2,5-DIOXO-3-PYRROLIDINYL)THIO)-1-OXOHEXYL)-L-LYSYL-N2-METHYL-N-(2-(METHYLAMINO)ETHYL)-L-.ALPHA.-ASPARAGINYL)-L-LYSYL-L-LEUCYL-L-.ALPHA.-ASPARTYL-L-ARGINYL-L-ISOLEUCYLGLYCYL-L-SERYL-L-METHIONYL-L-SERYLGLYCYL-L-LEUCYLGLYCYL-L-CYSTEINE CYCLIC (22->38)-DISULFIDE
  • TRANSCON CNP
  • TRANSCON CNP-38
  • TRANSCON-C-TYPE NATRIURETIC PEPTIDE-38




UNII - Y3BH8M899D | UNII Search Service